Clinical Features, Prognosis, and Long-Term Response to Ranibizumab of Macular CNVs in Pattern Dystrophies Spectrum: A Pilot Study

Clinical Features, Prognosis, and Long-Term Response to Ranibizumab of Macular CNVs in Pattern Dystrophies Spectrum: A Pilot Study

Introduction. To analyze the morphological and functional features of choroidal neovascularizations (CNVs) in eyes affected by pattern dystrophies (PD), evaluating their long-term response to intravitreal ranibizumab, and comparing them with CNVs in age-related macular degeneration (AMD). The mean g...

Full description

Bibliographic Details
Main Authors:	Lorenzo Casillo, Stefano Tricarico, Laura Contento, Enzo M. Vingolo
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2021/6698522

Similar Items

Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report
by: Alexandre Augusto Cabral de Mello Ventura, et al.
Published: (2011-08-01)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
by: Fong AH, et al.
Published: (2013-04-01)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
by: Canan H, et al.
Published: (2014-01-01)

Role of ranibizumab in management of macular degeneration
by: Singh Rishi, et al.
Published: (2007-01-01)

Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab
by: Yuxiang Hu, et al.
Published: (2019-08-01)

Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema
by: I-An Lai, et al.
Published: (2017-05-01)

Long-term outcomes of Ranibizumab treatment in neovascular age-related macular degeneration
by: Burak Simsek, et al.
Published: (2018-02-01)

Short-term results of intravitreal ranibizumab injection in eyes with diabetic macular edema
by: Ahmed Sharaf, et al.
Published: (2015-01-01)

Role of multifocal electroretinogram in the prediction of visual prognosis in patients with occult macular dystrophy
by: Marwa Abdelshafy, et al.
Published: (2020-01-01)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Sorsby macular dystrophy
by: Gopal S Pillai, et al.
Published: (2016-01-01)

Occult Macular Dystrophy
by: Işıl Sayman Muslubaş, et al.
Published: (2016-04-01)

Efficacy of macular focal/grid laser photocoagulation with Ranibizumab for diabetic macular edema
by: Hong-Miao Ren, et al.
Published: (2018-06-01)

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
by: Williams PD, et al.
Published: (2012-09-01)

Treatment of age-related macular degeneration: focus on ranibizumab
by: Martin S Spitzer, et al.
Published: (2008-03-01)

Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
by: Hüseyin Dündar, et al.
Published: (2014-10-01)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
by: Kim M, et al.
Published: (2013-11-01)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
by: Stewart MW
Published: (2013-06-01)

Copy number variations (CNVs) in Brazilian patients with autism spectrum disorder (ASD)
by: Costa, Claudia Ismania Samogy
Published: (2018)

Copy number variations (CNVs) in Brazilian patients with autism spectrum disorder (ASD)
by: Claudia Ismania Samogy Costa
Published: (2018)

Efficacy of intravitreal injection of Ranibizumab combined with macular grid photocoagulation for diabetic macular edema
by: Ping-Ping Ma, et al.
Published: (2020-12-01)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
by: Dervenis N, et al.
Published: (2016-06-01)

Efficacy of intravitreal ranibizumab injection combined with macular grid photocoagulation for diabetic macular edema
by: Hu-Lin Jiang, et al.
Published: (2014-07-01)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01)

Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema
by: Siddhi Goel, et al.
Published: (2019-01-01)

Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018-05-01)

Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
by: Yu-Dong Fu, et al.
Published: (2017-03-01)

INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO MALIGNANT HYPERTENSION
by: Raquel Claro Brito, et al.
Published: (2016-01-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

Intravitreal injection of Ranibizumab treating noninfectious uveitic macular edema
by: Hong-Bin Xie, et al.
Published: (2018-09-01)

Treatment of diabetic macular edema by Ranibizumab with laser photocoagulation therapy
by: Yan Li, et al.
Published: (2018-08-01)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
by: Alfredo García-Layana, et al.
Published: (2015-01-01)

Efficacy and safety of photocoagulation combined with Ranibizumab for diabetic macular edema
by: Kai Chen, et al.
Published: (2019-09-01)

Intravitreal injection of Ranibizumab combined with laser for diabetic macular edema
by: Yan-Xia Huang, et al.
Published: (2018-04-01)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
by: Matthews Jane P, et al.
Published: (2008-06-01)

Evaluation of Ranibizumab and PDT for patients with pathologic myopia and macular CNV
by: Jing Yan, et al.
Published: (2018-02-01)

Functional improvements of diabetic macular edema after treatment with Ranibizumab
by: Hussam O Elrashidy
Published: (2021-01-01)

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
by: Van Aken E, et al.
Published: (2020-12-01)

Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab
by: Lucia Gonzalez-Buendia, et al.
Published: (2017-08-01)

Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
by: Bekir Küçük, et al.
Published: (2018-04-01)